| 标题 |
47P First-line pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) in the China subpopulation from the phase III KEYNOTE-966 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:S. Qin; T. Liang; S. Gu; H. Gou; C. Peng; et al 出版日期:2024-09-17 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)